Last edition
News about Biotechnology
First Made in India COVID-19 tests kit by Mylab gets commercial approval from the government
Mylab is the first Indian company getting commercial COVID-19 PCR kit approved by CDSCO.Mylab COVID-19 test kits cost nearly one-fourth of the currently procured kits. Mylab uses advanced protocols which can reduces testing time by 65%
Biotechnology | 24/03/2020 | By Darshana | 1274
DST invites proposals for prevention and therapy of COVID-19
The Technology Development Board (TDB), a statutory body under Department of Science and Technology (DST) has invited proposal applications from Indian companies to address protection and home-based therapeutic respiratory intervention for coronavirus (COVID-19) patients.
Biotechnology | 24/03/2020 | By Darshana | 436
ICMR Upgrades 72 Labs For Testing COVID-19 And Revises Criteria For Testing
The Indian Council of Medical Research (ICMR), the apex health research body of India, has equipped 72 of its laboratories to test for the pandemic disease. In addition to these labs, 49 more laboratories under organizations such as Council of Scientific & Industrial Research (CSIR), Department of Biotechnology (DBT) and DRDO
Biotechnology | 18/03/2020 | By Darshana | 330
Serum Institute claims COVID-19 vaccine to be market ready by 2022
Serum Institute had partnered with the US-based biotech drug research company Codagenix three weeks ago to jointly develop a live-attenuated vaccine to fight the coronavirus
Biotechnology | 11/03/2020 | By Hemant | 571
Biocon receives 3 USFDA observations for insulin facility in Malaysia
At the conclusion of the inspection, the agency issued a Form 483 with three observations which we believe are procedural in nature
Biotechnology | 28/02/2020 | By Hemant | 254
Abbott launches new four-strain flu vaccine for wide protection against influenza
Globally approved, this 3rd generation quadrivalent vaccine, offers wide coverage protection against four flu virus strains for children and adults vs. three strains in previous generation Sub-unit vaccines offer similar immunization benefits with better tolerability compared to other flu vaccine types, with lesser side effects.
Biotechnology | 28/02/2020 | By Hemant | 266
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy